NO832811L - Fremgangsmaate ved fremstilling av anti-tumor glykoproteiner - Google Patents

Fremgangsmaate ved fremstilling av anti-tumor glykoproteiner

Info

Publication number
NO832811L
NO832811L NO832811A NO832811A NO832811L NO 832811 L NO832811 L NO 832811L NO 832811 A NO832811 A NO 832811A NO 832811 A NO832811 A NO 832811A NO 832811 L NO832811 L NO 832811L
Authority
NO
Norway
Prior art keywords
tumor
molecular weight
glycoprotein
cells
cbx
Prior art date
Application number
NO832811A
Other languages
English (en)
Norwegian (no)
Inventor
Haruo Ohnishi
Kazuo Yamaguchi
Yasuo Suzuki
Ei Mochida
Nobuo Mochida
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of NO832811L publication Critical patent/NO832811L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO832811A 1982-08-04 1983-08-03 Fremgangsmaate ved fremstilling av anti-tumor glykoproteiner NO832811L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57135852A JPS5925332A (ja) 1982-08-04 1982-08-04 抗腫瘍性糖蛋白質の製法

Publications (1)

Publication Number Publication Date
NO832811L true NO832811L (no) 1984-02-06

Family

ID=15161271

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832811A NO832811L (no) 1982-08-04 1983-08-03 Fremgangsmaate ved fremstilling av anti-tumor glykoproteiner

Country Status (21)

Country Link
JP (1) JPS5925332A (index.php)
KR (1) KR840006127A (index.php)
AU (1) AU1759283A (index.php)
BE (1) BE897470A (index.php)
BR (1) BR8304143A (index.php)
DD (1) DD213440A5 (index.php)
DE (1) DE3328239A1 (index.php)
DK (1) DK356483A (index.php)
FI (1) FI832776A7 (index.php)
FR (1) FR2531435A1 (index.php)
GB (1) GB2125048A (index.php)
GR (1) GR78638B (index.php)
IT (1) IT8348806A0 (index.php)
LU (1) LU84946A1 (index.php)
NL (1) NL8302765A (index.php)
NO (1) NO832811L (index.php)
PL (1) PL243306A1 (index.php)
PT (1) PT77154B (index.php)
SE (1) SE8304276L (index.php)
YU (1) YU161983A (index.php)
ZA (1) ZA835680B (index.php)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2161813B (en) * 1984-07-20 1988-07-13 Michiko Koga Anti-tumor agent
JP3439490B2 (ja) * 1992-09-28 2003-08-25 株式会社林原生物化学研究所 蛋白質とその蛋白質をコードするｄｎａ並びにその蛋白質の製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073293B1 (index.php) * 1969-12-31 1973-01-12 Pasteur Institut
WO1980002375A1 (en) * 1977-09-23 1980-11-13 Hem Res Inc High purity animal interferons

Also Published As

Publication number Publication date
NL8302765A (nl) 1984-03-01
AU1759283A (en) 1984-02-09
JPS5925332A (ja) 1984-02-09
BR8304143A (pt) 1984-03-13
PL243306A1 (en) 1984-08-27
GB2125048A (en) 1984-02-29
PT77154B (en) 1986-01-28
KR840006127A (ko) 1984-11-22
GB8320547D0 (en) 1983-09-01
FI832776L (fi) 1984-02-05
DD213440A5 (de) 1984-09-12
BE897470A (fr) 1984-02-06
DE3328239A1 (de) 1984-02-16
YU161983A (en) 1986-02-28
IT8348806A0 (it) 1983-08-03
PT77154A (en) 1983-09-01
SE8304276D0 (sv) 1983-08-04
LU84946A1 (fr) 1983-12-28
DK356483D0 (da) 1983-08-04
FI832776A7 (fi) 1984-02-05
GR78638B (index.php) 1984-09-27
FI832776A0 (fi) 1983-08-02
DK356483A (da) 1984-02-05
SE8304276L (sv) 1984-02-05
FR2531435A1 (fr) 1984-02-10
ZA835680B (en) 1984-08-29

Similar Documents

Publication Publication Date Title
FI72124C (fi) Foerfarande foer tillvaratagande av interferon.
US4571336A (en) Immune stimulation
AU590872B2 (en) Neovascularization inhibitors and methods for their production and use
US4869903A (en) Method of selectively inhibiting HIV
AU590543B2 (en) Purification of native colony stimulating factor-1
US4404188A (en) Purified Mullerian Inhibiting Substance and method of purification
JPH04504105A (ja) フォリスタチンおよびその精製法
AU724940B2 (en) Protein which induces interferon-gamma production by immunocompetent cell
DE3687097T2 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
DE3587526T2 (de) Serinproteaseinhibitoren und isolierungsverfahren dazu.
Dixon et al. Conversion of the N-terminal serine residue of corticotrophin into glycine
Schumacher et al. Biochemical, histochemical and cell biological investigations on the actions of mistletoe lectins I, II and III with human breast cancer cell lines
WO1996032123A1 (en) Pharmaceutical preparations derived from korean mistletoe
JPS6219525A (ja) 植物起源の生物活性物質の製造法および同物質含有組成物
US5547674A (en) Pharmaceutical preparations derived from European mistletoe
JPH0550273B2 (index.php)
NO832811L (no) Fremgangsmaate ved fremstilling av anti-tumor glykoproteiner
Ferrari et al. Toxicity and activity of purified trichosanthin
CA2193396A1 (en) A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof
EP0136093A2 (en) Anti-cancer factors
KR950008569B1 (ko) 신규 림포카인(lymphokine) 및 그 제조방법과 사용방법
GB2042558A (en) Interferon inducers, methods for their preparation, pharmaceutical compositions containing them and their use as medicaments
JP3677054B2 (ja) ヒトｔ細胞白血病ウィルス感染・増殖抑制剤
US7309501B2 (en) Conditioned media to inhibit growth of tumor cells
NO850152L (no) Fremgangsmaate ved fremstilling av human, endogen cancerregulerende faktor.